FDA To Consider More Studies Of Vertex/CRISPR Sickle Cell Gene Therapy
U.S. FDA’s team of reviewers has requested that the regulatory advisory panel assess the requirement for additional studies on the…
U.S. FDA’s team of reviewers has requested that the regulatory advisory panel assess the requirement for additional studies on the…
The scientists worry that the latest wave of genetic studies, including the CRISPR sickle cell study, may not have gotten…